Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-03-002843
Filing Date
2003-04-30
Accepted
2003-04-30 17:01:31
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDING 12/31/2002 d10ka.htm 10-K/A 1569571
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 2209
4 CERTIFICATION dex991.htm EX-99.1 7513
5 GRAPHIC g23675g97i12.jpg GRAPHIC 103074
  Complete submission text file 0001193125-03-002843.txt   1684141
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12465 | Film No.: 03673764
SIC: 2834 Pharmaceutical Preparations